Antiplatelet therapy in secondary stroke prevention - state of the art

被引：8

作者：

Diener, Hans-Christoph ^{[1
]}

Weimar, Christian

Weber, Ralph

机构：

[1] Univ Duisburg Essen, Dept Neurol, D-45122 Essen, Germany

来源：

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2010年 / 14卷 / 11期

关键词：

ischaemic stroke; transient ischaemic attack; antiplatelet; anticoagulation; secondary prevention; TRANSIENT ISCHEMIC ATTACK; PATENT FORAMEN OVALE; ACUTE CORONARY SYNDROMES; ATRIAL-FIBRILLATION; DOUBLE-BLIND; RECURRENT STROKE; VASCULAR EVENTS; EUROPEAN STROKE; PLUS ASPIRIN; RISK-FACTORS;

D O I：

10.1111/j.1582-4934.2010.01163.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Our objective is to provide the reader with an overview as well as an update on current antiplatelet therapy for secondary stroke prevention. Relevant journals were hand-searched by the authors to compile a broad but by far not comprehensive summary of innovative and clinically relevant studies. Aspirin, clopidogrel and the combination of dipyridamole plus aspirin are the cornerstone therapy in secondary prevention after non-cardio-embolic stroke or transient ischaemic attack. A head-to-head comparison showed no difference in the prevention of recurrent stroke between dipyridamole plus aspirin and clopidogrel. More potent antiplatelet drugs or the combination of aspirin and clopidogrel prevent more ischaemic events, but also lead to more bleeding complications. For secondary stroke prevention in patients with atrial fibrillation, oral anticoagulation is more effective than aspirin or the combination of aspirin and clopidogrel.

引用

页码：2552 / 2560

页数：9

共 68 条

[1] Emergency administration of abciximab for treatment of patients with acute ischemic stroke:: Results of an international phase III trial -: Abciximab in emergency treatment of stroke trial (AbESTT-II) [J].

Adams, Harold P., Jr. ;

Effron, Mark B. ;

Torner, James ;

Davalos, Antoni ;

Frayne, Judith ;

Teal, Philip ;

Leclerc, Jacques ;

Oemar, Barry ;

Padgett, Lakshmi ;

Barnathan, Elliot S. ;

Hacke, Werner .

STROKE, 2008, 39 (01) :87-99

[2] Emergency administration of abciximab for treatment of patients with acute ischemic stroke -: Results of a randomized phase 2 trial [J].

Adams, HP ;

Hacke, W ;

Oemar, B ;

Dávalos, A ;

Cook, RA ;

Trouillas, P ;

Fazekas, F ;

Bogousslavsky, J ;

Hilburn, J ;

Torner, J ;

Leclerc, J ;

Shuaib, A ;

Reid, P .

STROKE, 2005, 36 (04) :880-890

[3]

Adams HP, 2000, STROKE, V31, P601

[4] Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation - Pooled analysis of SPORTIF III and V clinical trials [J].

Akins, Paul T. ;

Feldman, Harvey A. ;

Zoble, Robert G. ;

Newman, David ;

Spitzer, Stefan G. ;

Diener, Hans-Christoph ;

Albers, Gregory W. .

STROKE, 2007, 38 (03) :874-880

[5] Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin [J].

Algra, A ;

Van Gijn, J .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02) :255-255

[6]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[7] Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke PRoFESS Subgroup Analysis [J].

Bath, Philip M. W. ;

Cotton, Daniel ;

Martin, Renee H. ;

Palesch, Yuko ;

Yusuf, Salim ;

Sacco, Ralph ;

Diener, Hans-Christoph ;

Estol, Conrado ;

Roberts, Robin .

STROKE, 2010, 41 (04) :732-738

[8] Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial [J].

Bhatt, Deepak L. ;

Flather, Marcus D. ;

Hacke, Werner ;

Berger, Peter B. ;

Black, Henry R. ;

Boden, William E. ;

Cacoub, Patrice ;

Cohen, Eric A. ;

Creager, Mark A. ;

Easton, J. Donald ;

Hamm, Christian W. ;

Hankey, Graeme J. ;

Johnston, S. Claiborne ;

Mak, Koon-Hou ;

Mas, Jean-Louis ;

Montalescot, Gilles ;

Pearson, Thomas A. ;

Steg, P. Gabriel ;

Steinhubl, Steven R. ;

Weber, Michael A. ;

Fabry-Ribaudo, Liz ;

Hu, Tingfei ;

Topol, Eric J. ;

Fox, A. A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (19) :1982-1988

[9] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].

Bhatt, DL ;

Fox, KAA ;

Hacke, W ;

Berger, PB ;

Black, HR ;

Boden, WE ;

Cacoub, P ;

Cohen, EA ;

Creager, MA ;

Easton, JD ;

Flather, MD ;

Haffner, SM ;

Hamm, CW ;

Hankey, GJ ;

Johnston, SC ;

Mak, KH ;

Mas, JL ;

Montalescot, G ;

Pearson, TA ;

Steg, PG ;

Steinhubl, SR ;

Weber, MA ;

Brennan, DM ;

Fabry-Ribaudo, L ;

Booth, J ;

Topol, EJ ;

Frye, RL ;

Amarenco, P ;

Brass, LM ;

Buyse, M ;

Cohen, LS ;

DeMets, DL ;

Fuster, V ;

Hart, RG ;

Marler, JR ;

McCarthy, C ;

Schoemig, A ;

Lincoff, AM ;

Brener, SJ ;

Sila, CA ;

Albuquerque, A ;

Aroutiounov, G ;

Artemiev, D ;

Atkeson, BG ;

Bartel, T ;

Basart, DCG ;

Lima, AB ;

Belli, G ;

Bordalo e Sa, AL ;

Bosch, X .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717

[10] Aspirin dose for the prevention of cardiovascular disease - A systematic review [J].

Campbell, Charles L. ;

Smyth, Susan ;

Montalescot, Gilles ;

Steinhubl, Steven R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (18) :2018-2024

← 1 2 3 4 5 6 7 →